Hyderabad: NATCO Pharma Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its finished dosage form (FDF) manufacturing facility in... At the conclusion of the inspection, the facility was issued four observations in Form 483.The company has now received the EIR from the US drug regulator, confirming the classification of the inspection as VAI.